Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Schwarer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cytopathology : Official Journal of the British Society for Clinical Cytology|May 10, 2007
Urinary cytology in multiple myelomaS Patil, A Schwarer, C McLean
Australian and New Zealand Journal of Medicine|December 16, 1998
Hydroxyurea-induced fever and hepatitisD A Westerman, A Schwarer, A P Grigg
Bone Marrow Transplantation|July 10, 2002
Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significanceY C Lee, N Came, A Schwarer, et al.
Journal of Immunological Methods|February 14, 1992
A rapid limiting dilution assay for measuring frequencies of alloreactive, interleukin-2-producing T cells in humansS Deacock, A Schwarer, R Batchelor, et al.
Tissue Antigens|April 21, 2007
14thInternational HLA and Immunogenetics Workshop: report on hematopoietic cell transplantationE Petersdorf, P Bardy, A Cambon-Thomsen, et al.
Blood Cancer Journal|May 13, 2014
Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myelomaP Campbell, P Walker, S Avery, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 2, 2014
Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantationJ Sasadeusz, H M Prince, A Schwarer, et al.
Bone Marrow Transplantation|November 10, 2009
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-upS Patil, A Spencer, A Schwarer, et al.
Internal Medicine Journal|July 5, 2012
High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemiaM Low, D Lee, J Coutsouvelis, et al.
Transplantation Proceedings|March 27, 2001
Clinical relevance of the minor histocompatibility antigen HA-1 in allogeneic bone marrow transplantation between HLA identical siblingsB D Tait, R Maddison, J McCluskey, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cytopathology : Official Journal of the British Society for Clinical Cytology|May 10, 2007
Urinary cytology in multiple myelomaS Patil, A Schwarer, C McLean
Australian and New Zealand Journal of Medicine|December 16, 1998
Hydroxyurea-induced fever and hepatitisD A Westerman, A Schwarer, A P Grigg
Bone Marrow Transplantation|July 10, 2002
Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significanceY C Lee, N Came, A Schwarer, et al.
Journal of Immunological Methods|February 14, 1992
A rapid limiting dilution assay for measuring frequencies of alloreactive, interleukin-2-producing T cells in humansS Deacock, A Schwarer, R Batchelor, et al.
Tissue Antigens|April 21, 2007
14thInternational HLA and Immunogenetics Workshop: report on hematopoietic cell transplantationE Petersdorf, P Bardy, A Cambon-Thomsen, et al.
Blood Cancer Journal|May 13, 2014
Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myelomaP Campbell, P Walker, S Avery, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 2, 2014
Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantationJ Sasadeusz, H M Prince, A Schwarer, et al.
Bone Marrow Transplantation|November 10, 2009
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-upS Patil, A Spencer, A Schwarer, et al.
Internal Medicine Journal|July 5, 2012
High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemiaM Low, D Lee, J Coutsouvelis, et al.
Transplantation Proceedings|March 27, 2001
Clinical relevance of the minor histocompatibility antigen HA-1 in allogeneic bone marrow transplantation between HLA identical siblingsB D Tait, R Maddison, J McCluskey, et al.
Pageof 2